Melanotan II: The Tanning and Libido Peptide Generating Research Interest

Melanotan II is one of the more provocative peptides in current research — it touches on skin, sexual function, and appetite in ways that make it genuinely interesting across multiple research disciplines. If you follow melanocortin receptor research, this one almost certainly has your attention.

What Is Melanotan II?

Melanotan II (MT-II) is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) — one of the body’s natural melanocortin peptides. It was originally developed at the University of Arizona in the 1980s as part of a research program aimed at finding a compound that could protect against UV-induced skin damage by promoting tanning without sun exposure.

The peptide acts on multiple melanocortin receptors (MC1R, MC3R, MC4R, MC5R), which is why its research profile extends well beyond skin pigmentation. Each receptor is found in different tissues and mediates different effects — making Melanotan II a wide-reaching tool in melanocortin system research.

What Does Research Show About Melanin Production and UV Protection?

The original research goal was to activate MC1R in melanocytes — the skin cells that produce melanin. Studies show that Melanotan II does this effectively. In research models:

• Studies show significant increases in melanin production following Melanotan II administration.
• Research in fair-skinned animal models demonstrated increased pigmentation and, in some studies, reduced UV-induced DNA damage compared to controls.
• Researchers have used Melanotan II in models studying skin cancer risk factors, where UV protection is a key variable.

Research on Libido and Melanocortin Receptors

This is where Melanotan II generated some of its most surprising research findings. During early human trials, researchers observed unexpected effects on sexual arousal — specifically, spontaneous erections in male subjects. This led to a significant new research direction focused on MC4R and sexual function.

Research suggests that melanocortin receptor activation — particularly MC4R in the central nervous system — plays a meaningful role in sexual arousal pathways. This finding eventually contributed to the development of PT-141 (bremelanotide), a related melanocortin peptide that has since received FDA approval for female sexual dysfunction. Melanotan II is still studied alongside PT-141 to better understand the melanocortin system’s role in sexual function.

Why Researchers Study It Alongside PT-141

PT-141 was directly derived from Melanotan II research — it is essentially a cyclic form of MT-II designed to isolate the sexual function effects while reducing some of the side effects observed with MT-II (particularly nausea and blood pressure changes). Researchers studying the melanocortin pathway often study both compounds in parallel to understand the receptor selectivity differences between them and what that means for downstream effects.

Melanotan II also continues to be studied for its effects on appetite regulation (through MC3R and MC4R) and metabolic function — another active area of melanocortin receptor research.

All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use.

Get research-grade Melanotan II at peptivigor.com — see Melanotan II 10mg. Use code LABVIP1 at checkout to save 15% on your order.